[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global OPO Infant Formula Market Insights, Forecast to 2026

August 2020 | 114 pages | ID: C97FADD41EA1EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
OPO Infant Formula market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global OPO Infant Formula market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the OPO Infant Formula market is segmented into
  • Cow Milk Formula
  • Goat Milk Formula
Segment by Application, the OPO Infant Formula market is segmented into
  • 0 - 6 Month
  • 6 - 12 Month
  • 12 - 36 Month
Regional and Country-level Analysis
The OPO Infant Formula market is analysed and market size information is provided by regions (countries).

The key regions covered in the OPO Infant Formula market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and OPO Infant Formula Market Share Analysis
OPO Infant Formula market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in OPO Infant Formula business, the date to enter into the OPO Infant Formula market, OPO Infant Formula product introduction, recent developments, etc.
The major vendors covered:
  • BiosTime
  • Nutriben
  • Ausnutria
  • HERDS
  • Milupa
  • Shanxi Yatai
  • Beingmate
  • Abbott
  • Brightdairy
  • Feihe
  • Wyeth Nutrition
  • Deloraine
  • Yili
  • Kabrita
1 STUDY COVERAGE

1.1 OPO Infant Formula Product Introduction
1.2 Market Segments
1.3 Key OPO Infant Formula Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
  1.4.1 Global OPO Infant Formula Market Size Growth Rate by Type
  1.4.2 Cow Milk Formula
  1.4.3 Goat Milk Formula
1.5 Market by Application
  1.5.1 Global OPO Infant Formula Market Size Growth Rate by Application
  1.5.2 0 - 6 Month
  1.5.3 6 - 12 Month
  1.5.4 12 - 36 Month
1.6 Coronavirus Disease 2019 (Covid-19): OPO Infant Formula Industry Impact
  1.6.1 How the Covid-19 is Affecting the OPO Infant Formula Industry
    1.6.1.1 OPO Infant Formula Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and OPO Infant Formula Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for OPO Infant Formula Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 EXECUTIVE SUMMARY

2.1 Global OPO Infant Formula Market Size Estimates and Forecasts
  2.1.1 Global OPO Infant Formula Revenue 2015-2026
  2.1.2 Global OPO Infant Formula Sales 2015-2026
2.2 OPO Infant Formula Market Size by Region: 2020 Versus 2026
  2.2.1 Global OPO Infant Formula Retrospective Market Scenario in Sales by Region: 2015-2020
  2.2.2 Global OPO Infant Formula Retrospective Market Scenario in Revenue by Region: 2015-2020

3 GLOBAL OPO INFANT FORMULA COMPETITOR LANDSCAPE BY PLAYERS

3.1 OPO Infant Formula Sales by Manufacturers
  3.1.1 OPO Infant Formula Sales by Manufacturers (2015-2020)
  3.1.2 OPO Infant Formula Sales Market Share by Manufacturers (2015-2020)
3.2 OPO Infant Formula Revenue by Manufacturers
  3.2.1 OPO Infant Formula Revenue by Manufacturers (2015-2020)
  3.2.2 OPO Infant Formula Revenue Share by Manufacturers (2015-2020)
  3.2.3 Global OPO Infant Formula Market Concentration Ratio (CR5 and HHI) (2015-2020)
  3.2.4 Global Top 10 and Top 5 Companies by OPO Infant Formula Revenue in 2019
  3.2.5 Global OPO Infant Formula Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 OPO Infant Formula Price by Manufacturers
3.4 OPO Infant Formula Manufacturing Base Distribution, Product Types
  3.4.1 OPO Infant Formula Manufacturers Manufacturing Base Distribution, Headquarters
  3.4.2 Manufacturers OPO Infant Formula Product Type
  3.4.3 Date of International Manufacturers Enter into OPO Infant Formula Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global OPO Infant Formula Market Size by Type (2015-2020)
  4.1.1 Global OPO Infant Formula Sales by Type (2015-2020)
  4.1.2 Global OPO Infant Formula Revenue by Type (2015-2020)
  4.1.3 OPO Infant Formula Average Selling Price (ASP) by Type (2015-2026)
4.2 Global OPO Infant Formula Market Size Forecast by Type (2021-2026)
  4.2.1 Global OPO Infant Formula Sales Forecast by Type (2021-2026)
  4.2.2 Global OPO Infant Formula Revenue Forecast by Type (2021-2026)
  4.2.3 OPO Infant Formula Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global OPO Infant Formula Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global OPO Infant Formula Market Size by Application (2015-2020)
  5.1.1 Global OPO Infant Formula Sales by Application (2015-2020)
  5.1.2 Global OPO Infant Formula Revenue by Application (2015-2020)
  5.1.3 OPO Infant Formula Price by Application (2015-2020)
5.2 OPO Infant Formula Market Size Forecast by Application (2021-2026)
  5.2.1 Global OPO Infant Formula Sales Forecast by Application (2021-2026)
  5.2.2 Global OPO Infant Formula Revenue Forecast by Application (2021-2026)
  5.2.3 Global OPO Infant Formula Price Forecast by Application (2021-2026)

6 NORTH AMERICA

6.1 North America OPO Infant Formula by Country
  6.1.1 North America OPO Infant Formula Sales by Country
  6.1.2 North America OPO Infant Formula Revenue by Country
  6.1.3 U.S.
  6.1.4 Canada
6.2 North America OPO Infant Formula Market Facts & Figures by Type
6.3 North America OPO Infant Formula Market Facts & Figures by Application

7 EUROPE

7.1 Europe OPO Infant Formula by Country
  7.1.1 Europe OPO Infant Formula Sales by Country
  7.1.2 Europe OPO Infant Formula Revenue by Country
  7.1.3 Germany
  7.1.4 France
  7.1.5 U.K.
  7.1.6 Italy
  7.1.7 Russia
7.2 Europe OPO Infant Formula Market Facts & Figures by Type
7.3 Europe OPO Infant Formula Market Facts & Figures by Application

8 ASIA PACIFIC

8.1 Asia Pacific OPO Infant Formula by Region
  8.1.1 Asia Pacific OPO Infant Formula Sales by Region
  8.1.2 Asia Pacific OPO Infant Formula Revenue by Region
  8.1.3 China
  8.1.4 Japan
  8.1.5 South Korea
  8.1.6 India
  8.1.7 Australia
  8.1.8 Taiwan
  8.1.9 Indonesia
  8.1.10 Thailand
  8.1.11 Malaysia
  8.1.12 Philippines
  8.1.13 Vietnam
8.2 Asia Pacific OPO Infant Formula Market Facts & Figures by Type
8.3 Asia Pacific OPO Infant Formula Market Facts & Figures by Application

9 LATIN AMERICA

9.1 Latin America OPO Infant Formula by Country
  9.1.1 Latin America OPO Infant Formula Sales by Country
  9.1.2 Latin America OPO Infant Formula Revenue by Country
  9.1.3 Mexico
  9.1.4 Brazil
  9.1.5 Argentina
9.2 Central & South America OPO Infant Formula Market Facts & Figures by Type
9.3 Central & South America OPO Infant Formula Market Facts & Figures by Application

10 MIDDLE EAST AND AFRICA

10.1 Middle East and Africa OPO Infant Formula by Country
  10.1.1 Middle East and Africa OPO Infant Formula Sales by Country
  10.1.2 Middle East and Africa OPO Infant Formula Revenue by Country
  10.1.3 Turkey
  10.1.4 Saudi Arabia
  10.1.5 U.A.E
10.2 Middle East and Africa OPO Infant Formula Market Facts & Figures by Type
10.3 Middle East and Africa OPO Infant Formula Market Facts & Figures by Application

11 COMPANY PROFILES

11.1 BiosTime
  11.1.1 BiosTime Corporation Information
  11.1.2 BiosTime Description, Business Overview and Total Revenue
  11.1.3 BiosTime Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 BiosTime OPO Infant Formula Products Offered
  11.1.5 BiosTime Recent Development
11.2 Nutriben
  11.2.1 Nutriben Corporation Information
  11.2.2 Nutriben Description, Business Overview and Total Revenue
  11.2.3 Nutriben Sales, Revenue and Gross Margin (2015-2020)
  11.2.4 Nutriben OPO Infant Formula Products Offered
  11.2.5 Nutriben Recent Development
11.3 Ausnutria
  11.3.1 Ausnutria Corporation Information
  11.3.2 Ausnutria Description, Business Overview and Total Revenue
  11.3.3 Ausnutria Sales, Revenue and Gross Margin (2015-2020)
  11.3.4 Ausnutria OPO Infant Formula Products Offered
  11.3.5 Ausnutria Recent Development
11.4 HERDS
  11.4.1 HERDS Corporation Information
  11.4.2 HERDS Description, Business Overview and Total Revenue
  11.4.3 HERDS Sales, Revenue and Gross Margin (2015-2020)
  11.4.4 HERDS OPO Infant Formula Products Offered
  11.4.5 HERDS Recent Development
11.5 Milupa
  11.5.1 Milupa Corporation Information
  11.5.2 Milupa Description, Business Overview and Total Revenue
  11.5.3 Milupa Sales, Revenue and Gross Margin (2015-2020)
  11.5.4 Milupa OPO Infant Formula Products Offered
  11.5.5 Milupa Recent Development
11.6 Shanxi Yatai
  11.6.1 Shanxi Yatai Corporation Information
  11.6.2 Shanxi Yatai Description, Business Overview and Total Revenue
  11.6.3 Shanxi Yatai Sales, Revenue and Gross Margin (2015-2020)
  11.6.4 Shanxi Yatai OPO Infant Formula Products Offered
  11.6.5 Shanxi Yatai Recent Development
11.7 Beingmate
  11.7.1 Beingmate Corporation Information
  11.7.2 Beingmate Description, Business Overview and Total Revenue
  11.7.3 Beingmate Sales, Revenue and Gross Margin (2015-2020)
  11.7.4 Beingmate OPO Infant Formula Products Offered
  11.7.5 Beingmate Recent Development
11.8 Abbott
  11.8.1 Abbott Corporation Information
  11.8.2 Abbott Description, Business Overview and Total Revenue
  11.8.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
  11.8.4 Abbott OPO Infant Formula Products Offered
  11.8.5 Abbott Recent Development
11.9 Brightdairy
  11.9.1 Brightdairy Corporation Information
  11.9.2 Brightdairy Description, Business Overview and Total Revenue
  11.9.3 Brightdairy Sales, Revenue and Gross Margin (2015-2020)
  11.9.4 Brightdairy OPO Infant Formula Products Offered
  11.9.5 Brightdairy Recent Development
11.10 Feihe
  11.10.1 Feihe Corporation Information
  11.10.2 Feihe Description, Business Overview and Total Revenue
  11.10.3 Feihe Sales, Revenue and Gross Margin (2015-2020)
  11.10.4 Feihe OPO Infant Formula Products Offered
  11.10.5 Feihe Recent Development
11.1 BiosTime
  11.1.1 BiosTime Corporation Information
  11.1.2 BiosTime Description, Business Overview and Total Revenue
  11.1.3 BiosTime Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 BiosTime OPO Infant Formula Products Offered
  11.1.5 BiosTime Recent Development
11.12 Deloraine
  11.12.1 Deloraine Corporation Information
  11.12.2 Deloraine Description, Business Overview and Total Revenue
  11.12.3 Deloraine Sales, Revenue and Gross Margin (2015-2020)
  11.12.4 Deloraine Products Offered
  11.12.5 Deloraine Recent Development
11.13 Yili
  11.13.1 Yili Corporation Information
  11.13.2 Yili Description, Business Overview and Total Revenue
  11.13.3 Yili Sales, Revenue and Gross Margin (2015-2020)
  11.13.4 Yili Products Offered
  11.13.5 Yili Recent Development
11.14 Kabrita
  11.14.1 Kabrita Corporation Information
  11.14.2 Kabrita Description, Business Overview and Total Revenue
  11.14.3 Kabrita Sales, Revenue and Gross Margin (2015-2020)
  11.14.4 Kabrita Products Offered
  11.14.5 Kabrita Recent Development

12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)

12.1 OPO Infant Formula Market Estimates and Projections by Region
  12.1.1 Global OPO Infant Formula Sales Forecast by Regions 2021-2026
  12.1.2 Global OPO Infant Formula Revenue Forecast by Regions 2021-2026
12.2 North America OPO Infant Formula Market Size Forecast (2021-2026)
  12.2.1 North America: OPO Infant Formula Sales Forecast (2021-2026)
  12.2.2 North America: OPO Infant Formula Revenue Forecast (2021-2026)
  12.2.3 North America: OPO Infant Formula Market Size Forecast by Country (2021-2026)
12.3 Europe OPO Infant Formula Market Size Forecast (2021-2026)
  12.3.1 Europe: OPO Infant Formula Sales Forecast (2021-2026)
  12.3.2 Europe: OPO Infant Formula Revenue Forecast (2021-2026)
  12.3.3 Europe: OPO Infant Formula Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific OPO Infant Formula Market Size Forecast (2021-2026)
  12.4.1 Asia Pacific: OPO Infant Formula Sales Forecast (2021-2026)
  12.4.2 Asia Pacific: OPO Infant Formula Revenue Forecast (2021-2026)
  12.4.3 Asia Pacific: OPO Infant Formula Market Size Forecast by Region (2021-2026)
12.5 Latin America OPO Infant Formula Market Size Forecast (2021-2026)
  12.5.1 Latin America: OPO Infant Formula Sales Forecast (2021-2026)
  12.5.2 Latin America: OPO Infant Formula Revenue Forecast (2021-2026)
  12.5.3 Latin America: OPO Infant Formula Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa OPO Infant Formula Market Size Forecast (2021-2026)
  12.6.1 Middle East and Africa: OPO Infant Formula Sales Forecast (2021-2026)
  12.6.2 Middle East and Africa: OPO Infant Formula Revenue Forecast (2021-2026)
  12.6.3 Middle East and Africa: OPO Infant Formula Market Size Forecast by Country (2021-2026)

13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key OPO Infant Formula Players (Opinion Leaders)

14 VALUE CHAIN AND SALES CHANNELS ANALYSIS

14.1 Value Chain Analysis
14.2 OPO Infant Formula Customers
14.3 Sales Channels Analysis
  14.3.1 Sales Channels
  14.3.2 Distributors

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Research Methodology
  16.1.1 Methodology/Research Approach
  16.1.2 Data Source
16.2 Author Details
LIST OF TABLES

Table 1. OPO Infant Formula Market Segments
Table 2. Ranking of Global Top OPO Infant Formula Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global OPO Infant Formula Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Cow Milk Formula
Table 5. Major Manufacturers of Goat Milk Formula
Table 6. COVID-19 Impact Global Market: (Four OPO Infant Formula Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for OPO Infant Formula Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for OPO Infant Formula Players to Combat Covid-19 Impact
Table 11. Global OPO Infant Formula Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global OPO Infant Formula Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global OPO Infant Formula Sales by Regions 2015-2020 (K MT)
Table 14. Global OPO Infant Formula Sales Market Share by Regions (2015-2020)
Table 15. Global OPO Infant Formula Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global OPO Infant Formula Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global OPO Infant Formula Sales Share by Manufacturers (2015-2020)
Table 18. Global OPO Infant Formula Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global OPO Infant Formula by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OPO Infant Formula as of 2019)
Table 20. OPO Infant Formula Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. OPO Infant Formula Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers OPO Infant Formula Price (2015-2020) (USD/MT)
Table 23. OPO Infant Formula Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers OPO Infant Formula Product Type
Table 25. Date of International Manufacturers Enter into OPO Infant Formula Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global OPO Infant Formula Sales by Type (2015-2020) (K MT)
Table 28. Global OPO Infant Formula Sales Share by Type (2015-2020)
Table 29. Global OPO Infant Formula Revenue by Type (2015-2020) (US$ Million)
Table 30. Global OPO Infant Formula Revenue Share by Type (2015-2020)
Table 31. OPO Infant Formula Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global OPO Infant Formula Sales by Application (2015-2020) (K MT)
Table 33. Global OPO Infant Formula Sales Share by Application (2015-2020)
Table 34. North America OPO Infant Formula Sales by Country (2015-2020) (K MT)
Table 35. North America OPO Infant Formula Sales Market Share by Country (2015-2020)
Table 36. North America OPO Infant Formula Revenue by Country (2015-2020) (US$ Million)
Table 37. North America OPO Infant Formula Revenue Market Share by Country (2015-2020)
Table 38. North America OPO Infant Formula Sales by Type (2015-2020) (K MT)
Table 39. North America OPO Infant Formula Sales Market Share by Type (2015-2020)
Table 40. North America OPO Infant Formula Sales by Application (2015-2020) (K MT)
Table 41. North America OPO Infant Formula Sales Market Share by Application (2015-2020)
Table 42. Europe OPO Infant Formula Sales by Country (2015-2020) (K MT)
Table 43. Europe OPO Infant Formula Sales Market Share by Country (2015-2020)
Table 44. Europe OPO Infant Formula Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe OPO Infant Formula Revenue Market Share by Country (2015-2020)
Table 46. Europe OPO Infant Formula Sales by Type (2015-2020) (K MT)
Table 47. Europe OPO Infant Formula Sales Market Share by Type (2015-2020)
Table 48. Europe OPO Infant Formula Sales by Application (2015-2020) (K MT)
Table 49. Europe OPO Infant Formula Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific OPO Infant Formula Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific OPO Infant Formula Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific OPO Infant Formula Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific OPO Infant Formula Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific OPO Infant Formula Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific OPO Infant Formula Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific OPO Infant Formula Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific OPO Infant Formula Sales Market Share by Application (2015-2020)
Table 58. Latin America OPO Infant Formula Sales by Country (2015-2020) (K MT)
Table 59. Latin America OPO Infant Formula Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa OPO Infant Formula Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America OPO Infant Formula Revenue Market Share by Country (2015-2020)
Table 62. Latin America OPO Infant Formula Sales by Type (2015-2020) (K MT)
Table 63. Latin America OPO Infant Formula Sales Market Share by Type (2015-2020)
Table 64. Latin America OPO Infant Formula Sales by Application (2015-2020) (K MT)
Table 65. Latin America OPO Infant Formula Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa OPO Infant Formula Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa OPO Infant Formula Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa OPO Infant Formula Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa OPO Infant Formula Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa OPO Infant Formula Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa OPO Infant Formula Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa OPO Infant Formula Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa OPO Infant Formula Sales Market Share by Application (2015-2020)
Table 74. BiosTime Corporation Information
Table 75. BiosTime Description and Major Businesses
Table 76. BiosTime OPO Infant Formula Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. BiosTime Product
Table 78. BiosTime Recent Development
Table 79. Nutriben Corporation Information
Table 80. Nutriben Description and Major Businesses
Table 81. Nutriben OPO Infant Formula Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Nutriben Product
Table 83. Nutriben Recent Development
Table 84. Ausnutria Corporation Information
Table 85. Ausnutria Description and Major Businesses
Table 86. Ausnutria OPO Infant Formula Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Ausnutria Product
Table 88. Ausnutria Recent Development
Table 89. HERDS Corporation Information
Table 90. HERDS Description and Major Businesses
Table 91. HERDS OPO Infant Formula Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. HERDS Product
Table 93. HERDS Recent Development
Table 94. Milupa Corporation Information
Table 95. Milupa Description and Major Businesses
Table 96. Milupa OPO Infant Formula Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Milupa Product
Table 98. Milupa Recent Development
Table 99. Shanxi Yatai Corporation Information
Table 100. Shanxi Yatai Description and Major Businesses
Table 101. Shanxi Yatai OPO Infant Formula Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Shanxi Yatai Product
Table 103. Shanxi Yatai Recent Development
Table 104. Beingmate Corporation Information
Table 105. Beingmate Description and Major Businesses
Table 106. Beingmate OPO Infant Formula Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Beingmate Product
Table 108. Beingmate Recent Development
Table 109. Abbott Corporation Information
Table 110. Abbott Description and Major Businesses
Table 111. Abbott OPO Infant Formula Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Abbott Product
Table 113. Abbott Recent Development
Table 114. Brightdairy Corporation Information
Table 115. Brightdairy Description and Major Businesses
Table 116. Brightdairy OPO Infant Formula Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Brightdairy Product
Table 118. Brightdairy Recent Development
Table 119. Feihe Corporation Information
Table 120. Feihe Description and Major Businesses
Table 121. Feihe OPO Infant Formula Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Feihe Product
Table 123. Feihe Recent Development
Table 124. Wyeth Nutrition Corporation Information
Table 125. Wyeth Nutrition Description and Major Businesses
Table 126. Wyeth Nutrition OPO Infant Formula Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. Wyeth Nutrition Product
Table 128. Wyeth Nutrition Recent Development
Table 129. Deloraine Corporation Information
Table 130. Deloraine Description and Major Businesses
Table 131. Deloraine OPO Infant Formula Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Deloraine Product
Table 133. Deloraine Recent Development
Table 134. Yili Corporation Information
Table 135. Yili Description and Major Businesses
Table 136. Yili OPO Infant Formula Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. Yili Product
Table 138. Yili Recent Development
Table 139. Kabrita Corporation Information
Table 140. Kabrita Description and Major Businesses
Table 141. Kabrita OPO Infant Formula Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. Kabrita Product
Table 143. Kabrita Recent Development
Table 144. Global OPO Infant Formula Sales Forecast by Regions (2021-2026) (K MT)
Table 145. Global OPO Infant Formula Sales Market Share Forecast by Regions (2021-2026)
Table 146. Global OPO Infant Formula Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 147. Global OPO Infant Formula Revenue Market Share Forecast by Regions (2021-2026)
Table 148. North America: OPO Infant Formula Sales Forecast by Country (2021-2026) (K MT)
Table 149. North America: OPO Infant Formula Revenue Forecast by Country (2021-2026) (US$ Million)
Table 150. Europe: OPO Infant Formula Sales Forecast by Country (2021-2026) (K MT)
Table 151. Europe: OPO Infant Formula Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Asia Pacific: OPO Infant Formula Sales Forecast by Region (2021-2026) (K MT)
Table 153. Asia Pacific: OPO Infant Formula Revenue Forecast by Region (2021-2026) (US$ Million)
Table 154. Latin America: OPO Infant Formula Sales Forecast by Country (2021-2026) (K MT)
Table 155. Latin America: OPO Infant Formula Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Middle East and Africa: OPO Infant Formula Sales Forecast by Country (2021-2026) (K MT)
Table 157. Middle East and Africa: OPO Infant Formula Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 159. Key Challenges
Table 160. Market Risks
Table 161. Main Points Interviewed from Key OPO Infant Formula Players
Table 162. OPO Infant Formula Customers List
Table 163. OPO Infant Formula Distributors List
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. OPO Infant Formula Product Picture
Figure 2. Global OPO Infant Formula Sales Market Share by Type in 2020 & 2026
Figure 3. Cow Milk Formula Product Picture
Figure 4. Goat Milk Formula Product Picture
Figure 5. Global OPO Infant Formula Sales Market Share by Application in 2020 & 2026
Figure 6. 0 - 6 Month
Figure 7. 6 - 12 Month
Figure 8. 12 - 36 Month
Figure 9. OPO Infant Formula Report Years Considered
Figure 10. Global OPO Infant Formula Market Size 2015-2026 (US$ Million)
Figure 11. Global OPO Infant Formula Sales 2015-2026 (K MT)
Figure 12. Global OPO Infant Formula Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global OPO Infant Formula Sales Market Share by Region (2015-2020)
Figure 14. Global OPO Infant Formula Sales Market Share by Region in 2019
Figure 15. Global OPO Infant Formula Revenue Market Share by Region (2015-2020)
Figure 16. Global OPO Infant Formula Revenue Market Share by Region in 2019
Figure 17. Global OPO Infant Formula Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by OPO Infant Formula Revenue in 2019
Figure 19. OPO Infant Formula Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global OPO Infant Formula Sales Market Share by Type (2015-2020)
Figure 21. Global OPO Infant Formula Sales Market Share by Type in 2019
Figure 22. Global OPO Infant Formula Revenue Market Share by Type (2015-2020)
Figure 23. Global OPO Infant Formula Revenue Market Share by Type in 2019
Figure 24. Global OPO Infant Formula Market Share by Price Range (2015-2020)
Figure 25. Global OPO Infant Formula Sales Market Share by Application (2015-2020)
Figure 26. Global OPO Infant Formula Sales Market Share by Application in 2019
Figure 27. Global OPO Infant Formula Revenue Market Share by Application (2015-2020)
Figure 28. Global OPO Infant Formula Revenue Market Share by Application in 2019
Figure 29. North America OPO Infant Formula Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America OPO Infant Formula Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America OPO Infant Formula Sales Market Share by Country in 2019
Figure 32. North America OPO Infant Formula Revenue Market Share by Country in 2019
Figure 33. U.S. OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America OPO Infant Formula Market Share by Type in 2019
Figure 38. North America OPO Infant Formula Market Share by Application in 2019
Figure 39. Europe OPO Infant Formula Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe OPO Infant Formula Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe OPO Infant Formula Sales Market Share by Country in 2019
Figure 42. Europe OPO Infant Formula Revenue Market Share by Country in 2019
Figure 43. Germany OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 46. France OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe OPO Infant Formula Market Share by Type in 2019
Figure 54. Europe OPO Infant Formula Market Share by Application in 2019
Figure 55. Asia Pacific OPO Infant Formula Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific OPO Infant Formula Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific OPO Infant Formula Sales Market Share by Region in 2019
Figure 58. Asia Pacific OPO Infant Formula Revenue Market Share by Region in 2019
Figure 59. China OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 60. China OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 66. India OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific OPO Infant Formula Market Share by Type in 2019
Figure 82. Asia Pacific OPO Infant Formula Market Share by Application in 2019
Figure 83. Latin America OPO Infant Formula Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America OPO Infant Formula Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America OPO Infant Formula Sales Market Share by Country in 2019
Figure 86. Latin America OPO Infant Formula Revenue Market Share by Country in 2019
Figure 87. Mexico OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America OPO Infant Formula Market Share by Type in 2019
Figure 94. Latin America OPO Infant Formula Market Share by Application in 2019
Figure 95. Middle East and Africa OPO Infant Formula Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa OPO Infant Formula Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa OPO Infant Formula Sales Market Share by Country in 2019
Figure 98. Middle East and Africa OPO Infant Formula Revenue Market Share by Country in 2019
Figure 99. Turkey OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E OPO Infant Formula Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E OPO Infant Formula Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa OPO Infant Formula Market Share by Type in 2019
Figure 106. Middle East and Africa OPO Infant Formula Market Share by Application in 2019
Figure 107. BiosTime Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Nutriben Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Ausnutria Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. HERDS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Milupa Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Shanxi Yatai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Beingmate Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Brightdairy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Feihe Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Wyeth Nutrition Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Deloraine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Yili Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Kabrita Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. North America OPO Infant Formula Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. North America OPO Infant Formula Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Europe OPO Infant Formula Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Europe OPO Infant Formula Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Asia Pacific OPO Infant Formula Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Asia Pacific OPO Infant Formula Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Latin America OPO Infant Formula Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 128. Latin America OPO Infant Formula Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Middle East and Africa OPO Infant Formula Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 130. Middle East and Africa OPO Infant Formula Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Porter's Five Forces Analysis
Figure 132. Channels of Distribution
Figure 133. Distributors Profiles
Figure 134. Bottom-up and Top-down Approaches for This Report
Figure 135. Data Triangulation
Figure 136. Key Executives Interviewed


More Publications